MedDataX Logo

Iron Deficiency Anemia in Childern With Liver Cirrhosis

NCT ID: NCT03482076

Last Updated: 2018-03-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-03-01

Study Completion Date

2020-06-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Iron deficiency anemia is a common complication of liver cirrhosis in childern and may affects there life this study to improve the outcome of these patients

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

IRON DEFICIENCY ANEMIA IN RELATION TO PINCH STRENGTH AND HAND DEXTERITY IN PRESCHOOL CHILDREN

NCT05959122

Iron Deficiency Anemia
COMPLETED

Maternal Iron Deficiency and/or Iron Deficiency Anemia to Neonatal Hemoglobin Concentration and Iron Stores

NCT06871917

Relation, Mother-Child
NOT_YET_RECRUITING

Iron Profile in Patients With Congenital Cyanotic Heart Disease

NCT04104061

Congenital; Cyanotic Heart Disease
UNKNOWN

Hospitalization & Mortality in Patients With Iron Deficiency CKD and HF Treated With i.v. Iron.

NCT02392910

Iron Deficiency Heart Failure Chronic Kidney Disease
COMPLETED PHASE4

Predisposing Factors for Liver Diseases in Patients With Chronic Hemolytic Anemia

NCT06743854

Hemolytic Anemia, Chronic Liver Diseases
NOT_YET_RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients with cirrhosis are at risk of developing both IDA and anemia of chronic disease concomitantly, and there adverse effects can deteriorate general condition and affect of quality of life in these patients .Also because it is easier to correct IDA than anemia of chronic disease, so this study of the prevalence of IDA helping us in the diagnosis and treatment of IDA and can reduce the need for other diagnostic tests and improve the quality of life in patients with cirrhosis .

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Iron Deficiency, Anaemia in Children Liver Cirrhosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

transferrin receptor concentration

Prevelance of iron deficiency in this patients

Group Type OTHER

transferrin receptor concentration

Intervention Type DIAGNOSTIC_TEST

Sandwich radio-imunoassay

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

transferrin receptor concentration

Sandwich radio-imunoassay

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* all childern with liver cirrhosis in GIT and hepatology unit

Exclusion Criteria

* Neonates less than one month
* childern with other liver diseases
Minimum Eligible Age

1 Month

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Assiut University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Bahaa Khaled Mohamed Mohamed

assistant lecturer

Responsibility Role PRINCIPAL_INVESTIGATOR

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Bahaa Khaled Mohamed

Role: CONTACT

[email protected]
+201002755105 ext. 002

Nagla Hassan Ibrahim

Role: CONTACT

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

DBK

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Lactoferrin Versus Ferrous Fumarate for Treatment of Mild to Moderate Iron Deficiency Anemia During Pregnancy
NCT03484845 UNKNOWN PHASE1/PHASE2
Treatment of Iron Deficiency Anaemia in Pregnancy Study
NCT03725150 COMPLETED
Iron Status in BTM With Blood Transfusion
NCT04947540 UNKNOWN
Detection Of β-thalassemia Carriers In Assiut
NCT03822585 UNKNOWN NA
Iron Deficiency in Pediatric Heart Surgery
NCT06276608 RECRUITING
Iron Deficiency Anaemia in Pregnant Patients Presenting for Antenatal Care
NCT05157828 COMPLETED
Impact of Intravenous Iron on Musculoskeletal Function in Older Adults
NCT05708170 NOT_YET_RECRUITING PHASE4
Relationship Between Blood Groups , Iron Deficiency Anemia and Helicobacter Pylori in Children.
NCT05841433 UNKNOWN
Study on the Effect of Different Risk Factors on the Growth Parameters of Thalassemic Patients in Assiut (AUCH)
NCT05303506 UNKNOWN
Investigation of Hypophosphataemia Following Intravenous Iron
NCT04502784 UNKNOWN
Efficacy of Treatment of Postpartum Anaemia With Intravenous Iron Versus Oral Iron in a Tertiary Hospital in South East, Nigeria.
NCT07110935 COMPLETED PHASE1/PHASE2
Red Cell Distribution Width Index Versus Red Cell Distribution Width as Discriminating Guide for Iron Deficiency Anaemia and Beta Thalassemia Trait .
NCT03868306 UNKNOWN
Adherence of Iron Succinylate Therapy in Pregnancy
NCT03873571 WITHDRAWN
Ferritin as a Predictor for Anemia in Pregnancy
NCT03565198 UNKNOWN
Iron Deficiency Anemia, Iron Supplementation and Genomic Stability in Infants
NCT03359447 UNKNOWN PHASE4
Treatment Adherence and Fatigue in Iron Deficiency
NCT05909891 COMPLETED NA
Iron Metabolism Disorders in Patients With Sepsis or Septic Shock.
NCT05217836 UNKNOWN
Short Term Oral Iron Supplementation in Systolic Heart Failure Patients Suffering From Iron Deficiency Anemia
NCT02998697 COMPLETED PHASE2/PHASE3
A Study of Impact of Anemia on Morbidity and Mortality in Children With Dilated Cardiomyopathy
NCT03214757 UNKNOWN
Iron Prophylaxis for Anemia in Infants With Cyanotic Congenital Heart Disease
NCT00459225 WITHDRAWN NA
Relative Contributions of Red Cell Catabolism and Dietary Absorption to Fetal Iron Accretion During Pregnancy
NCT01588665 COMPLETED
Intravenous Iron in paTients With Heart failURe and Reduced Ejection fracTion (HFREF) pLus Iron dEficiency
NCT03079518 COMPLETED PHASE2
Evaluate the PK, Safety, Tolerability of Ferric Maltol at 3 Dosage Levels in Paediatric Subjects With Iron Deficiency
NCT03181451 COMPLETED PHASE1
Treatment of Iron Deficiency Anemia With Pregnancy
NCT02005588 COMPLETED EARLY_PHASE1
Intravenous Versus Oral Iron in Late Pregnancy: Results of Treatment
NCT00746551 COMPLETED PHASE4